198 related articles for article (PubMed ID: 25384216)
21. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
[TBL] [Abstract][Full Text] [Related]
22. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells.
Weinhold N; Meissner T; Johnson DC; Seckinger A; Moreaux J; Försti A; Chen B; Nickel J; Chubb D; Rawstron AC; Doughty C; Dahir NB; Begum DB; Young K; Walker BA; Hoffmann P; Nöthen MM; Davies FE; Klein B; Goldschmidt H; Morgan GJ; Houlston RS; Hose D; Hemminki K
Haematologica; 2015 Mar; 100(3):e110-3. PubMed ID: 25480495
[No Abstract] [Full Text] [Related]
23. [Regulation of c-myc expression in leukemic cell line Meg-01 by the death domain of Fas gene].
Liu H; Shan J; Tang S; Liu S
Zhonghua Xue Ye Xue Za Zhi; 2001 Jan; 22(1):9-12. PubMed ID: 11877042
[TBL] [Abstract][Full Text] [Related]
24. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
[TBL] [Abstract][Full Text] [Related]
25. Activation of gp130 signaling in T cells drives T
Baumgartner F; Bamopoulos SA; Faletti L; Hsiao HJ; Holz M; Gonzalez-Menendez I; Solé-Boldo L; Horne A; Gosavi S; Özerdem C; Singh N; Liebig S; Ramamoorthy S; Lehmann M; Demel U; Kühl AA; Wartewig T; Ruland J; Wunderlich FT; Schick M; Walther W; Rose-John S; Haas S; Quintanilla-Martinez L; Feske S; Ehl S; Glauben R; Keller U
Sci Signal; 2024 Feb; 17(824):eadc9662. PubMed ID: 38377177
[TBL] [Abstract][Full Text] [Related]
26. Teleost IL-6 promotes antibody production through STAT3 signaling via IL-6R and gp130.
Kaneda M; Odaka T; Suetake H; Tahara D; Miyadai T
Dev Comp Immunol; 2012 Oct; 38(2):224-31. PubMed ID: 22469658
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy.
Selander KS; Li L; Watson L; Merrell M; Dahmen H; Heinrich PC; Müller-Newen G; Harris KW
Cancer Res; 2004 Oct; 64(19):6924-33. PubMed ID: 15466183
[TBL] [Abstract][Full Text] [Related]
28. IL-6 signal transduction and its physiological roles: the signal orchestration model.
Kamimura D; Ishihara K; Hirano T
Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
[TBL] [Abstract][Full Text] [Related]
29. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
30. Forced dimerization of gp130 leads to constitutive STAT3 activation, cytokine-independent growth, and blockade of differentiation of embryonic stem cells.
Stuhlmann-Laeisz C; Lang S; Chalaris A; Krzysztof P; Enge S; Eichler J; Klingmüller U; Samuel M; Ernst M; Rose-John S; Scheller J
Mol Biol Cell; 2006 Jul; 17(7):2986-95. PubMed ID: 16624864
[TBL] [Abstract][Full Text] [Related]
31. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
[TBL] [Abstract][Full Text] [Related]
32. Due to interleukin-6 type cytokine redundancy only glycoprotein 130 receptor blockade efficiently inhibits myeloma growth.
Burger R; Günther A; Klausz K; Staudinger M; Peipp M; Penas EM; Rose-John S; Wijdenes J; Gramatzki M
Haematologica; 2017 Feb; 102(2):381-390. PubMed ID: 27658435
[TBL] [Abstract][Full Text] [Related]
33. Proteomic Characterization of the World Trade Center dust-activated mdig and c-myc signaling circuit linked to multiple myeloma.
Wu K; Li L; Thakur C; Lu Y; Zhang X; Yi Z; Chen F
Sci Rep; 2016 Nov; 6():36305. PubMed ID: 27833099
[TBL] [Abstract][Full Text] [Related]
34. Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation.
Shain KH; Yarde DN; Meads MB; Huang M; Jove R; Hazlehurst LA; Dalton WS
Cancer Res; 2009 Feb; 69(3):1009-15. PubMed ID: 19155309
[TBL] [Abstract][Full Text] [Related]
35. A gp130 interleukin-6 transducer-dependent SCID model of human multiple myeloma.
Rebouissou C; Wijdenes J; Autissier P; Tarte K; Costes V; Liautard J; Rossi JF; Brochier J; Klein B
Blood; 1998 Jun; 91(12):4727-37. PubMed ID: 9616171
[TBL] [Abstract][Full Text] [Related]
36. Study of Fibronectin Type III-Like Domains Role in Activation of gp130 Receptor.
Stepanov AV; Rybinets AS; Dronina MA; Deev SM
Bull Exp Biol Med; 2016 May; 161(1):72-4. PubMed ID: 27270939
[TBL] [Abstract][Full Text] [Related]
37. Concomitant gain of 1q21 and MYC translocation define a poor prognostic subgroup of hyperdiploid multiple myeloma.
Weinhold N; Kirn D; Seckinger A; Hielscher T; Granzow M; Bertsch U; Egerer G; Salwender H; Blau IW; Weisel K; Hillengass J; Raab MS; Hose D; Goldschmidt H; Jauch A
Haematologica; 2016 Mar; 101(3):e116-9. PubMed ID: 26611471
[No Abstract] [Full Text] [Related]
38. The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.
Maura F; Coffey DG; Stein CK; Braggio E; Ziccheddu B; Sharik ME; Du MT; Tafoya Alvarado Y; Shi CX; Zhu YX; Meermeier EW; Morgan GJ; Landgren O; Bergsagel PL; Chesi M
Nat Commun; 2024 May; 15(1):3844. PubMed ID: 38714690
[TBL] [Abstract][Full Text] [Related]
39. Multiple myeloma-initiating cells.
Hosen N
Int J Hematol; 2013 Mar; 97(3):306-12. PubMed ID: 23420183
[TBL] [Abstract][Full Text] [Related]
40. Intracellular signaling prevents effective blockade of oncogenic gp130 mutants by neutralizing antibodies.
Rinis N; Küster A; Schmitz-Van de Leur H; Mohr A; Müller-Newen G
Cell Commun Signal; 2014 Mar; 12():14. PubMed ID: 24612692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
